LPCN
Lipocine Inc
NASDAQ: LPCN · HEALTHCARE · BIOTECHNOLOGY
$2.33
+0.00% today
Updated 2026-05-01
Market cap
$19.02M
P/E ratio
—
P/S ratio
9.62x
EPS (TTM)
$-1.77
Dividend yield
—
52W range
$2 – $12
Volume
0.5M
Lipocine Inc (LPCN) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+4.8%
Last 4 quarters
Revenue YoY growth
-67.2%
Most recent quarter
EPS YoY growth
-227.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+6.7%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+14.1%
2026-03-10
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-10 | $-0.42 | +31.1% | $7.88 | $8.99 | +14.1% |
| 2025-11-06 | $-0.59 | -9.3% | $2.56 | $2.54 | -0.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.61 | $-0.42 | +31.1% | $1.15M | -67.2% |
| 2025-09-30 | $-0.54 | $-0.59 | -9.3% | $114574.00 | — |
| 2025-06-30 | $-0.40 | $-0.41 | -2.5% | $622849.00 | +595.4% |
| 2025-03-31 | $-0.35 | $-0.35 | +0.0% | $93864.00 | -98.8% |
| 2024-12-31 | $-0.40 | $0.33 | +182.5% | $3.49M | +1515.0% |
| 2024-09-30 | $-0.48 | $-0.41 | +14.6% | — | — |
| 2024-06-30 | $-0.78 | $-0.57 | +26.9% | $89565.00 | — |
| 2024-03-31 | $-0.68 | $0.66 | +197.1% | $7.62M | +13751.9% |
| 2023-12-31 | $-0.47 | $-0.42 | +10.6% | $216188.00 | — |
| 2023-09-30 | $-0.60 | $-1.27 | -111.7% | $-3.12M | — |
| 2023-06-30 | $-0.64 | $-0.68 | -6.3% | — | — |
| 2023-03-31 | $-0.42 | $-0.68 | -61.9% | $54990.00 | — |
Frequently asked questions
Has Lipocine Inc beaten earnings estimates?
Lipocine Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +4.8% over the last 4 quarters.
How does LPCN stock react to earnings?
LPCN stock has moved an average of +6.7% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Lipocine Inc's revenue growth rate?
Lipocine Inc reported year-over-year revenue growth of -67.2% in its most recent quarter, with EPS growing -227.3% year-over-year.